Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
From - Diagnostic Testing & Emerging Technologies
A novel fingerstick test may improve access to Toxoplasma gondii testing for pregnant women, according to…
From - Diagnostic Testing & Emerging Technologies
Artificial intelligence- (AI-) based technology is beginning to penetrate health care. Like most other clinical decision-making, several early AI applications rely upon…
From - Diagnostic Testing & Emerging Technologies
A group of blood metabolites help detect some children with autism spectrum disorder (ASD), according to a study published…
From - Diagnostic Testing & Emerging Technologies
The incidence of tickborne infections is on the rise in the United States. Yet, prevention and management of these infections are…
From - Diagnostic Testing & Emerging Technologies
Preimplantation genetic testing for aneuploidy (PGT-A) can mitigate the negative effects of maternal age on in vitro fertilization (IVF) outcomes by…
From - Diagnostic Testing & Emerging Technologies
Lung cancer-related testing is receiving a lot of attention, but recent results appear to show mixed benefits for these emerging tests…